Description
Clinical Description
AMiKO CMCA 1x10ml is a professional aesthetic skin-rejuvenation solution developed for use within clinic-based anti-ageing and skin revitalisation protocols. The formulation combines CMCA (carboxymethylcellulose-based complex activity) technology with active skin-conditioning ingredients intended to support hydration, skin quality improvement, and superficial rejuvenation procedures.
The product is positioned within the category of professional peel and revitalisation treatments commonly used in aesthetic medicine for dull skin, uneven texture, dehydration, and visible signs of skin ageing. Public distributor documentation identifies the product as a sterile professional-use solution supplied in a 10 mL vial presentation suitable for practitioner-administered treatment protocols.
Unlike traditional volumising dermal fillers, AMiKO CMCA is designed primarily for skin conditioning and revitalisation rather than structural augmentation. The formulation is intended for use by qualified medical or aesthetic professionals following manufacturer guidance and appropriate patient assessment. Detailed ingredient concentrations and full IFU injection parameters are not comprehensively available within public manufacturer documentation at the time of writing.
Short Marketing Description
AMiKO CMCA 1x10ml is a professional aesthetic rejuvenation product formulated for clinic-based skin conditioning and revitalisation treatments. The solution is commonly incorporated into protocols targeting skin hydration, texture refinement, and visible signs of skin fatigue or ageing.
The product may be used as part of professional anti-ageing treatment plans where practitioners aim to support overall skin appearance and improve superficial skin quality. AMiKO CMCA is supplied in a convenient 10 mL professional-use vial suitable for aesthetic clinic protocols.
As with all professional aesthetic products, administration should be performed only by qualified practitioners operating under appropriate aseptic conditions and according to manufacturer guidance. Individual treatment planning should always be based on clinical assessment and patient suitability.
What AMiKO CMCA 1x10ml Is Similar To
AMiKO CMCA 1x10ml belongs to the category of professional skin revitalisation and peel-associated aesthetic treatments. Comparable products may include biorevitalisation systems and superficial rejuvenation solutions such as PRX-T33®, BioRePeelCl3®, and selected non-volumising skin-conditioning protocols used in aesthetic medicine.
Unlike cross-linked hyaluronic acid dermal fillers designed for volume restoration, products in this category focus more on skin quality improvement, hydration support, and superficial rejuvenation. AMiKO CMCA is positioned closer to professional revitalisation systems rather than contouring fillers.
Compared with injectable skin boosters such as Profhilo® or Sunekos®, AMiKO CMCA appears more aligned with topical or professional peel-associated rejuvenation approaches rather than deep dermal volumisation. However, publicly available data regarding formulation technology and clinical longevity remain limited.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
Publicly available supplier information suggests AMiKO CMCA may be used in professional rejuvenation protocols involving:
- Face
- Neck
- Décolletage
- Areas showing superficial skin ageing or dehydration
- Practitioner-selected skin revitalisation areas
Specific manufacturer-approved treatment indications are not fully detailed in publicly accessible IFU documentation.
Usage / Administration (IFU-Only Section)
According to publicly accessible distributor information:
- Injection depth: not provided by manufacturer
- Volume per treatment point: not provided by manufacturer
- Needle gauge: not provided by manufacturer
- Frequency / number of sessions: not provided by manufacturer
- Product format: professional-use revitalisation solution supplied in a 10 mL vial
- Professional-use statement: intended for administration by qualified aesthetic or medical professionals under appropriate aseptic conditions
Detailed administration protocols are not comprehensively available in public manufacturer IFU documentation at the time of writing.
Some practitioners may incorporate AMiKO CMCA into combined rejuvenation or peel protocols; these approaches are not included within publicly available official manufacturer guidance.
Ingredient List
Publicly available formulation information remains limited. Reported or referenced components include:
- CMCA-based revitalisation complex
- Skin-conditioning and hydration-support ingredients
- Hyaluronic acid concentration: not provided by manufacturer
- Lidocaine content: not provided by manufacturer
- Stabilising excipients and buffers: not provided by manufacturer
Practitioners should review official product packaging and manufacturer documentation for the complete verified ingredient list before clinical use.
Presentation & Longevity
- Packaging: 1 × 10 mL vial
- Product category: professional skin revitalisation / peel-associated treatment
- Sterile professional-use format
- Shelf life: not publicly specified
- Longevity or duration of results: not provided by manufacturer
Treatment outcomes and maintenance intervals may vary depending on practitioner protocol, skin condition, and combination treatment plans.
Safety Notes / Contraindications
As with all professional aesthetic rejuvenation products, AMiKO CMCA should only be used following appropriate patient assessment and professional clinical judgement.
Contraindications and precautions may include:
- Known hypersensitivity to any formulation component
- Active skin infection, inflammation, or irritation at the treatment site
- Use during active dermatological flare-ups unless clinically assessed
- Avoidance in patients unsuitable for professional peel or revitalisation procedures
Transient redness, irritation, or skin sensitivity may occur following professional aesthetic treatments.
Because complete IFU safety data are not publicly available, practitioners should consult official manufacturer documentation before use.
Regulatory Status
Public supplier listings identify AMiKO CMCA as a professional aesthetic-use product intended for clinical rejuvenation protocols.
- CE marking: verify via product packaging or official IFU
- UKCA status: not publicly specified
- FDA clearance: not publicly specified
- Regulatory classification not specified in public documentation; verify on the product pack or manufacturer’s IFU.
FAQ
What is AMiKO CMCA 1x10ml used for?
AMiKO CMCA 1x10ml is used within professional aesthetic medicine protocols aimed at skin revitalisation and superficial rejuvenation. The product is commonly associated with treatments targeting dull skin, dehydration, uneven texture, and visible signs of skin ageing. It is intended exclusively for professional clinical use.
Is AMiKO CMCA a dermal filler?
AMiKO CMCA is not primarily positioned as a traditional volumising dermal filler. Instead, it is generally described as a skin-conditioning or revitalisation product used within aesthetic treatment protocols. Its intended purpose appears focused on skin quality support rather than deep structural augmentation or contour restoration.
Can AMiKO CMCA be combined with other aesthetic treatments?
Some practitioners incorporate revitalisation products such as AMiKO CMCA into broader skin-rejuvenation plans involving peels, microneedling, or injectable protocols. However, combination approaches should always follow manufacturer guidance, patient suitability assessment, and professional clinical judgement. Public IFU documentation does not fully specify combination-treatment recommendations.
How long do results from AMiKO CMCA treatments last?
Public manufacturer documentation does not specify an exact duration of results for AMiKO CMCA treatments. Longevity may vary depending on skin condition, practitioner protocol, maintenance scheduling, and adjunctive skincare. Patients commonly require personalised treatment planning based on clinical assessment and treatment goals.
Is AMiKO CMCA suitable for all skin types?
Professional revitalisation products are generally selected following practitioner assessment of skin condition, sensitivity, and treatment suitability. Patients with active infections, significant irritation, or hypersensitivity to formulation components may not be suitable candidates. A full consultation and clinical evaluation should be completed before treatment.
